Upgrade to SI Premium - Free Trial

WAVE Life Sciences (WVE)

4.86 +0.16 (3.40%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference September 3, 2026 4:05 PM - StreetInsider Form 4 Wave Life Sciences, Inc. For: Aug 11 Filed by: Wagner Heidi L August 13, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Aug 12 Filed by: Rawcliffe Adrian August 13, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Aug 11 Filed by: TAKANASHI KEN August 13, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Aug 11 Filed by: Tan Aik Na August 13, 2026 9:00 PM - SEC Filing Form SCHEDULE 13D/A Wave Life Sciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. August 11, 2026 4:40 PM - SEC Filing Form 144 Wave Life Sciences, Inc. Filed by: Wagner Heidi L August 11, 2026 4:31 PM - SEC Filing Wave Life Sciences moves its parent company from Singapore to Delaware August 10, 2026 8:30 AM - StreetInsider Wave Life Sciences Announces Completion of Redomiciliation to Delaware August 10, 2026 8:30 AM - StreetInsider Form POS AM Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form POSASR Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form 15-12G Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form 8-K12B Wave Life Sciences, Inc. For: Aug 07 August 7, 2026 4:52 PM - SEC Filing Wave Life Sciences to complete Delaware redomiciliation on Aug. 7 August 5, 2026 4:06 PM - StreetInsider Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware August 5, 2026 4:06 PM - Globe NewsWire Wave Life Sciences to Present at Upcoming Investor Conferences August 4, 2026 8:30 AM - StreetInsider WAVE Life Sciences (WVE) PT Lowered to $23 at Mizuho August 4, 2026 6:39 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE) August 3, 2026 6:58 AM - StreetInsider WAVE Life Sciences (WVE) PT Lowered to $22 at B.Riley July 31, 2026 8:16 AM - StreetInsider Form 10-Q Wave Life Sciences Ltd. For: Jun 30 July 30, 2026 7:51 AM - SEC Filing WAVE Life Sciences (WVE) Misses Q2 EPS by 4c July 30, 2026 7:45 AM - StreetInsider Form 8-K Wave Life Sciences Ltd. For: Jul 30 July 30, 2026 7:38 AM - SEC Filing Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update July 30, 2026 7:30 AM - StreetInsider Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026 July 23, 2026 8:30 AM - StreetInsider Wave Life Sciences schedules Singapore court hearing for US redomiciliation July 7, 2026 4:15 PM - StreetInsider Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation July 7, 2026 4:15 PM - StreetInsider Form 8-K Wave Life Sciences Ltd. For: Jun 22 June 26, 2026 8:30 AM - SEC Filing Wave Life Sciences starts Phase 2a obesity trial for WVE-007 drug June 24, 2026 8:30 AM - StreetInsider Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases June 24, 2026 8:30 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE) June 11, 2026 6:43 AM - StreetInsider Full Article List